Compound 2374
Identifiers
- Common name: NV05
- Canonical SMILES:
CCN(CC)CCCNC(=O)Cn1nc(C)n2c3ccccc3c(Br)c2c1=O
- IUPAC name:
2-{10-bromo-4-methyl-1-oxo-1H,2H-[1,2,4]triazino[4,5-a]indol-2-yl}-N-[3-(diethylamino)propyl]acetamide
- InChi:
InChI=1S/C20H26BrN5O2/c1-4-24(5-2)12-8-11-22-17(27)13-25-20(28)19-18(21)15-9-6-7-10-16(15)26(19)14(3)23-25/h6-7,9-10H,4-5,8,11-13H2,1-3H3,(H,22,27)
- InChiKey:
ZXVVXFDFZKBBSI-UHFFFAOYSA-N
External links
![]() 168317720 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
UHRF1 / H3 | 5.17 | breast cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 447.13 g/mol | |||
HBA | 7 | |||
HBD | 1 | |||
HBA + HBD | 8 | |||
AlogP | 1.45 | |||
TPSA | 71.14 | |||
RB | 8 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1177/2472555218766278 | NV05 | UHRF1 Q96T88 |
H32 Q71DI3 |
Biochemical assay | Isothermal Titration Calorimetry | pKd (dissociation constant, -log10) | 5.17 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4746 | CCX-354 | DB12963 | |
0.4293 | Trazodone | DB00656 | |
0.4122 | Ibrutinib | DB09053 | |
0.4105 | 1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide | DB06909 | |
0.4104 | N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide | DB08349 | |
0.4007 | Danicopan | DB15401 | |
0.3991 | Avadomide | DB14857 | |
0.3981 | 6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE | DB07218 | |
0.3968 | Futibatinib | DB15149 | |
0.3913 | Rabeximod | DB05772 | |
0.3863 | GSK-1004723 | DB12806 | |
0.3776 | MK-6186 | DB12999 | |
0.3756 | Halofuginone | DB04866 | |
0.3750 | (2S,3S)-3-AMINO-4-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-5-YLCYCLOHEXYL)BUTANAMIDE | DB07135 | |
0.3744 | 1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine | DB08054 |